Matthew A. Rose

Matthew Rose serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions, from market research and solicitation development to contract award and administration. He plays a critical role in ensuring compliance with federal procurement regulations while aligning acquisitions with agency mission needs. His portfolio primarily encompasses technical and scientific services, with a focus on life sciences, laboratory testing, and specialized manufacturing. Rose routinely handles competitive sealed bidding and negotiated procurements under the Federal Acquisition Regulation, emphasizing transparency, fairness, and value-driven outcomes. Matthew Rose maintains a broad network of vendors across specialized technical sectors, engaging with both large prime contractors and niche suppliers capable of delivering high-complexity goods and services. His contracting patterns reflect a preference for open competition, with no set-asides utilized in recent awards, indicating a focus on selecting the most technically qualified offerors regardless of business size or socioeconomic status. He cultivates long-term vendor relationships grounded in performance accountability and regulatory adherence, ensuring consistent delivery of mission-critical products and services. His procurement strategy reflects a strong orientation toward non-set-aside competitions, with 100% of recent awards issued under unrestricted solicitations. While he does not prioritize 8(a), HUBZone, or SDVOSB programs, his approach demonstrates a commitment to full and open competition as the primary mechanism for achieving best value. This pattern suggests a focus on technical merit and capability over socioeconomic preferences, consistent with mission-critical requirements where specialized expertise outweighs socioeconomic targeting. Matthew Rose’s primary procurement focus lies in NAICS 541940 (Veterinary Services), 339113 (Surgical Appliance and Supplies Manufacturing), 325412 (Pharmaceutical Preparation Manufacturing), 541712 (Research and Development in Life Sciences), and 541380 (Testing Laboratories). He regularly acquires laboratory testing protocols, pharmaceutical formulations, medical devices, and R&D services requiring stringent regulatory compliance, particularly under FDA and CDC standards. His expertise spans the intersection of biomedical science and federal procurement, ensuring that acquisitions meet both technical and regulatory benchmarks.